GeneticPredispositionMorpheaSelf-examinationPaclitaxelMRIKappaEpsilonBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55MethotrexateEstrogenER-GermlineMutationCDK4/6InhibitorsEstradiolAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerCachexiaPalpationExcisionalBiopsyPalbociclibCAMTyrosine-KinaseInhibitorAbsoluteRiskLymphoscintigraphyBrachytherapyDown-StagingACChemotherapyHER-2AntiemeticPhyllodesTumorProgestinAlopeciaFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.Mammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltApoptosisAdvocacyOligometastasesStagingCyclophosphamideRaloxifeneChemotherapy1 in 8womenAdenocarcinomaER+HormoneReceptorStatusMastodyniaChemopreventionPathologicResponseGuaranteedRenewableInsuranceRADDocetaxelNodePositiveBreastTomosynthesisBreastCancerCo-survivorBevacizumabIn-situCarcinomaAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenHerceptinTriplePositiveBreastCancerKi-67RateLumpPhysicalactivity mayreduce therisk of breastcancersAdjuvantTherapyMultifocalTumorsTamoxifenCytotoxicGeneMutationFamilyHistoryNodeNegativeAyurvedaBiopsyMultimodalityTherapyDimplingMegestrolAcetateLCISFibroadenomaGailModelCystTripleNegativeBreastCancerCheckpointInhibitorLapatinibInvasiveBreastCancerWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.ECOGScorePagetDiseaseCMFChemotherapyMastectomyCytostaticRadiotherapyCapecitabineEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearAnastrozoleRelapseLymphNodeStatusCalcificationsAntibodyTherapyAngiogenesisAxillarySamplingGeneticCounselingIntraductalPapilloma5-FluorouracilMetastasisBOCANeoadjuvantTherapyTumorGradeFlowCytometryWomen ages40+ shouldhave a clinicalbreast examat least yearlyGenomicTestingFISHPrecisionMedicineAromataseInhibitorsDefinitiveSurgeryHormoneReplacementTherapyPI3KinaseInhibitorsDoxorubicinmTORInhibitorsSERMLumpectomyDoseDenseTherapyNeoplasmEGFR(epidermalgrowth factorreceptor)ImmunotherapyBilateralProphylacticMastectomyPARPInhibitorsBRCAGeneOvarianSuppressionBI-RADSGeneticPredispositionMorpheaSelf-examinationPaclitaxelMRIKappaEpsilonBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55MethotrexateEstrogenER-GermlineMutationCDK4/6InhibitorsEstradiolAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerCachexiaPalpationExcisionalBiopsyPalbociclibCAMTyrosine-KinaseInhibitorAbsoluteRiskLymphoscintigraphyBrachytherapyDown-StagingACChemotherapyHER-2AntiemeticPhyllodesTumorProgestinAlopeciaFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.Mammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltApoptosisAdvocacyOligometastasesStagingCyclophosphamideRaloxifeneChemotherapy1 in 8womenAdenocarcinomaER+HormoneReceptorStatusMastodyniaChemopreventionPathologicResponseGuaranteedRenewableInsuranceRADDocetaxelNodePositiveBreastTomosynthesisBreastCancerCo-survivorBevacizumabIn-situCarcinomaAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenHerceptinTriplePositiveBreastCancerKi-67RateLumpPhysicalactivity mayreduce therisk of breastcancersAdjuvantTherapyMultifocalTumorsTamoxifenCytotoxicGeneMutationFamilyHistoryNodeNegativeAyurvedaBiopsyMultimodalityTherapyDimplingMegestrolAcetateLCISFibroadenomaGailModelCystTripleNegativeBreastCancerCheckpointInhibitorLapatinibInvasiveBreastCancerWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.ECOGScorePagetDiseaseCMFChemotherapyMastectomyCytostaticRadiotherapyCapecitabineEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearAnastrozoleRelapseLymphNodeStatusCalcificationsAntibodyTherapyAngiogenesisAxillarySamplingGeneticCounselingIntraductalPapilloma5-FluorouracilMetastasisBOCANeoadjuvantTherapyTumorGradeFlowCytometryWomen ages40+ shouldhave a clinicalbreast examat least yearlyGenomicTestingFISHPrecisionMedicineAromataseInhibitorsDefinitiveSurgeryHormoneReplacementTherapyPI3KinaseInhibitorsDoxorubicinmTORInhibitorsSERMLumpectomyDoseDenseTherapyNeoplasmEGFR(epidermalgrowth factorreceptor)ImmunotherapyBilateralProphylacticMastectomyPARPInhibitorsBRCAGeneOvarianSuppressionBI-RADS

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
  1. Genetic Predisposition
  2. Morphea
  3. Self-examination
  4. Paclitaxel
  5. MRI
  6. Kappa Epsilon
  7. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  8. Methotrexate
  9. Estrogen
  10. ER-
  11. Germline Mutation
  12. CDK4/6 Inhibitors
  13. Estradiol
  14. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  15. Cachexia
  16. Palpation
  17. Excisional Biopsy
  18. Palbociclib
  19. CAM
  20. Tyrosine-Kinase Inhibitor
  21. Absolute Risk
  22. Lymphoscintigraphy
  23. Brachytherapy
  24. Down-Staging
  25. AC Chemotherapy
  26. HER-2
  27. Antiemetic
  28. Phyllodes Tumor
  29. Progestin
  30. Alopecia
  31. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  32. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  33. Apoptosis
  34. Advocacy
  35. Oligometastases
  36. Staging
  37. Cyclophosphamide
  38. Raloxifene
  39. Chemotherapy
  40. 1 in 8 women
  41. Adenocarcinoma
  42. ER+
  43. Hormone Receptor Status
  44. Mastodynia
  45. Chemoprevention
  46. Pathologic Response
  47. Guaranteed Renewable Insurance
  48. RAD
  49. Docetaxel
  50. Node Positive
  51. Breast Tomosynthesis
  52. Breast Cancer
  53. Co-survivor
  54. Bevacizumab
  55. In-situ Carcinoma
  56. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  57. Herceptin
  58. Triple Positive Breast Cancer
  59. Ki-67 Rate
  60. Lump
  61. Physical activity may reduce the risk of breast cancers
  62. Adjuvant Therapy
  63. Multifocal Tumors
  64. Tamoxifen
  65. Cytotoxic
  66. Gene Mutation
  67. Family History
  68. Node Negative
  69. Ayurveda
  70. Biopsy
  71. Multimodality Therapy
  72. Dimpling
  73. Megestrol Acetate
  74. LCIS
  75. Fibroadenoma
  76. Gail Model
  77. Cyst
  78. Triple Negative Breast Cancer
  79. Checkpoint Inhibitor
  80. Lapatinib
  81. Invasive Breast Cancer
  82. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  83. ECOG Score
  84. Paget Disease
  85. CMF Chemotherapy
  86. Mastectomy
  87. Cytostatic
  88. Radiotherapy
  89. Capecitabine
  90. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  91. Anastrozole
  92. Relapse
  93. Lymph Node Status
  94. Calcifications
  95. Antibody Therapy
  96. Angiogenesis
  97. Axillary Sampling
  98. Genetic Counseling
  99. Intraductal Papilloma
  100. 5-Fluorouracil
  101. Metastasis
  102. BOCA
  103. Neoadjuvant Therapy
  104. Tumor Grade
  105. Flow Cytometry
  106. Women ages 40+ should have a clinical breast exam at least yearly
  107. Genomic Testing
  108. FISH
  109. Precision Medicine
  110. Aromatase Inhibitors
  111. Definitive Surgery
  112. Hormone Replacement Therapy
  113. PI3 Kinase Inhibitors
  114. Doxorubicin
  115. mTOR Inhibitors
  116. SERM
  117. Lumpectomy
  118. Dose Dense Therapy
  119. Neoplasm
  120. EGFR (epidermal growth factor receptor)
  121. Immunotherapy
  122. Bilateral Prophylactic Mastectomy
  123. PARP Inhibitors
  124. BRCA Gene
  125. Ovarian Suppression
  126. BI-RADS